8 February 2012, 10:03 pm
Oslo, Norway, 9 February 2012 - Algeta ASA (OSE: ALGETA.OL - News), a company focused on the development of novel targeted cancer therapeutics, announces its results for the fourth quarter and full year 2011. A ...... Read More »